A cost-effective plan for global testing - An infection rate stratified, algorith guided, multiple-level, continuously pooled testing strategy

The most effective measure to prevent or stop the spread of infectious diseases is the early identification and isolation of infected individuals through comprehensive screening. At present, in the COVID-19 pandemic, such screening is often limited to isolated regions as determined by local governme...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The Science of the total environment 2021-04, Vol.765
Hauptverfasser: Gu, Tianshu, Yao, Lan, Meng, Xia, Graff, J. Carolyn, Thomason, Donald, Li, Jing, Dong, Wei, Jiao, Yan, Aleya, Lotfi, Maida, Marcello, Wang, Cong-Yi, Zangerl, Barbara, Genini, Sem, Ray, Kunal, Goldman, Emanuel, Ji, Jiafu, Alexandrov, Andrei, Sun, Dianjun, Gu, Weikuan, Wang, Yongjun
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The most effective measure to prevent or stop the spread of infectious diseases is the early identification and isolation of infected individuals through comprehensive screening. At present, in the COVID-19 pandemic, such screening is often limited to isolated regions as determined by local governments. Screening of potentially infectious individuals should be conducted through coordinated national or global unified actions. Our current research focuses on using resources to conduct comprehensive national and regional regular testing with a risk rate based, algorithmic guided, multiple-level, pooled testing strategy. Here, combining methodologies with mathematical logistic models, we present an analytic procedure of an overall plan for coordinating state, national, or global testing. The proposed plan includes three parts 1) organization, resource allocation, and distribution; 2) screening based on different risk levels and business types; and 3) algorithm guided, multiple level, continuously screening the entire population in a region. This strategy will overcome the false positive and negative results in the polymerase chain reaction (PCR) test and missing samples during initial tests. Based on our proposed protocol, the population screening of 300,000,000 in the US can be done weekly with between 15,000,000 and 6,000,000 test kits. The strategy can be used for population screening for current COVID-19 and any future severe infectious disease when drugs or vaccines are not available.
ISSN:0048-9697
1879-1026
DOI:10.1016/j.scitotenv.2020.144251